Medical Xpress news

Medical Xpress / Cancer cells hijack a fatty acid to escape immune attack in liver metastases

Liver metastases are among the most common and deadly forms of cancer spread. Now, researchers at VIB and KU Leuven, with international collaborators, have discovered how cancer cells exploit a fatty acid abundant in the ...

Aug 5, 2026
Medical Xpress / How home gardens can reduce risk of type 2 diabetes

People with home gardens are less likely to develop type 2 diabetes, a University of Queensland study has found, planting fresh evidence that gardens and green spaces should be a priority in urban planning.

Aug 5, 2026
Medical Xpress / Dementia after age 90: Study clarifies who may be at higher risk

It may seem natural to assume that people experience cognitive decline after age 90, but until recently, researchers had limited evidence about how advanced age affects the brain. This major knowledge gap will need to be ...

Aug 5, 2026
Medical Xpress / How 'good' bacteria from fecal transplants reduce peanut allergy

Some 33 million Americans have severe food allergies. Now, researchers at Boston Children's Hospital may have found a promising solution. In a small clinical trial, Rima Rachid, M.D., director of the Food Allergy Program ...

Aug 5, 2026
Medical Xpress / Immune cell dysfunction, not absence, defines skin cancer in immunosuppressed patients

Researchers at The University of Texas MD Anderson Cancer Center have discovered that immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting immune cells found in immunocompetent patients, ...

Aug 5, 2026
Medical Xpress / GLP-1 drug linked to heart benefits for high-risk patients

Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart ...

Aug 5, 2026
Medical Xpress / Most people with atypical Alzheimer's may be ineligible for new therapies

Many people with less common forms of Alzheimer's disease may not qualify for newer anti-amyloid treatments designed to slow the disease, according to a study published Aug. 5, 2026, in Neurology.

Aug 5, 2026
Medical Xpress / Childhood physical illnesses linked to increased risk of mental health disorders in autistic young adults

Mental health conditions are more common among autistic individuals than in the general population, but knowledge about how physical and mental health interact over time has been limited. In the new study, researchers analyzed ...

Aug 5, 2026
Medical Xpress / Containment costs reveal when pandemic measures should shift from none to intensive

In the event of a pandemic, every society is confronted with the question: How can the spread of an infectious disease be effectively contained without restricting daily life more than necessary? Measures such as mandatory ...

Aug 5, 2026
Medical Xpress / New biobank of tumor models reveals cancers' weak spots

A new open resource of cancer models has enabled researchers to create the first large-scale map of the genes that cancers rely on to survive, offering new avenues for research into better and less toxic treatments for patients.

Aug 5, 2026
Medical Xpress / RNA technology improves insulin-producing cell transplantation outcomes

Researchers from the Rolf Luft Research Center for Diabetes and Endocrinology at Karolinska Institutet have developed a targeted RNA technology to prepare pancreatic islet cells for transplantation. The technology briefly ...

Aug 5, 2026
Medical Xpress / Targeting sensory nerves after growth plate injuries may bolster healing

In January this year, a team of Johns Hopkins Medicine investigators, led by pathologist Aaron W. James, MD, Ph.D., discovered that sensory neurons in skeletal tissue are constantly sensing their environment and quickly respond ...

Aug 5, 2026